Selected research
Industry Research
Vaccines For Children Industry Research Report 2026
Market perspective
The global Vaccines For Children market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Vaccines For Children is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Vaccines For Children is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Vaccines For Children is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Vaccines For Children include GSK, CSL, Hissen, J&J(Crucell), Jintan, MedImmune LLC, Tiantan, Hualan and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Vaccines For Children market in terms of revenue (US$ million) and, where applicable, sales volume (K Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Vaccines For Children Market by Company
GSK
CSL
Hissen
J&J(Crucell)
Jintan
MedImmune LLC
Tiantan
Hualan
Pfizer
Kangtai
Merck
Sanofi
China National Biotec
Vaccines For Children Segment by Type
Recombinant Vaccines
Polysaccharide Vaccines
Viral Vaccines
Others
Vaccines For Children Segment by Application
Hospital
Clinic
Vaccines For Children Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccines For Children market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccines For Children and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccines For Children.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Vaccines For Children manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Vaccines For Children by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Vaccines For Children in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Recombinant Vaccines
- Polysaccharide Vaccines
- Viral Vaccines
- Others
Applications
- Hospital
- Clinic
Companies covered
- GSK
- CSL
- Hissen
- J&J(Crucell)
- Jintan
- MedImmune LLC
- Tiantan
- Hualan
- Pfizer
- Kangtai
- Merck
- Sanofi
- China National Biotec
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Vaccines For Children Market Size (2021-2032)
- 2.2.2 Global Vaccines For Children Sales (2021-2032)
- 2.2.3 Global Vaccines For Children Market Average Price (2021-2032)
- 2.3 Vaccines For Children by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Recombinant Vaccines
- 2.3.3 Polysaccharide Vaccines
- 2.3.4 Viral Vaccines
- 2.3.5 Others
- 2.4 Vaccines For Children by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Vaccines For Children Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Vaccines For Children Sales (K Doses) of Manufacturers (2021-2026)
- 3.3 Global Vaccines For Children Revenue of Manufacturers (2021-2026)
- 3.4 Global Vaccines For Children Average Price by Manufacturers (2021-2026)
- 3.5 Global Vaccines For Children Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Vaccines For Children, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Vaccines For Children, Product Type & Application
- 3.8 Global Manufacturers of Vaccines For Children, Established Date
- 3.9 Global Vaccines For Children Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GSK
- 4.1.1 GSK Company Information
- 4.1.2 GSK Business Overview
- 4.1.3 GSK Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GSK Vaccines For Children Product Portfolio
- 4.1.5 GSK Recent Developments
- 4.2 CSL
- 4.2.1 CSL Company Information
- 4.2.2 CSL Business Overview
- 4.2.3 CSL Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CSL Vaccines For Children Product Portfolio
- 4.2.5 CSL Recent Developments
- 4.3 Hissen
- 4.3.1 Hissen Company Information
- 4.3.2 Hissen Business Overview
- 4.3.3 Hissen Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hissen Vaccines For Children Product Portfolio
- 4.3.5 Hissen Recent Developments
- 4.4 J&J(Crucell)
- 4.4.1 J&J(Crucell) Company Information
- 4.4.2 J&J(Crucell) Business Overview
- 4.4.3 J&J(Crucell) Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 J&J(Crucell) Vaccines For Children Product Portfolio
- 4.4.5 J&J(Crucell) Recent Developments
- 4.5 Jintan
- 4.5.1 Jintan Company Information
- 4.5.2 Jintan Business Overview
- 4.5.3 Jintan Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jintan Vaccines For Children Product Portfolio
- 4.5.5 Jintan Recent Developments
- 4.6 MedImmune LLC
- 4.6.1 MedImmune LLC Company Information
- 4.6.2 MedImmune LLC Business Overview
- 4.6.3 MedImmune LLC Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 MedImmune LLC Vaccines For Children Product Portfolio
- 4.6.5 MedImmune LLC Recent Developments
- 4.7 Tiantan
- 4.7.1 Tiantan Company Information
- 4.7.2 Tiantan Business Overview
- 4.7.3 Tiantan Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Tiantan Vaccines For Children Product Portfolio
- 4.7.5 Tiantan Recent Developments
- 4.8 Hualan
- 4.8.1 Hualan Company Information
- 4.8.2 Hualan Business Overview
- 4.8.3 Hualan Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hualan Vaccines For Children Product Portfolio
- 4.8.5 Hualan Recent Developments
- 4.9 Pfizer
- 4.9.1 Pfizer Company Information
- 4.9.2 Pfizer Business Overview
- 4.9.3 Pfizer Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pfizer Vaccines For Children Product Portfolio
- 4.9.5 Pfizer Recent Developments
- 4.10 Kangtai
- 4.10.1 Kangtai Company Information
- 4.10.2 Kangtai Business Overview
- 4.10.3 Kangtai Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Kangtai Vaccines For Children Product Portfolio
- 4.10.5 Kangtai Recent Developments
- 4.11 Merck
- 4.11.1 Merck Company Information
- 4.11.2 Merck Business Overview
- 4.11.3 Merck Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Merck Vaccines For Children Product Portfolio
- 4.11.5 Merck Recent Developments
- 4.12 Sanofi
- 4.12.1 Sanofi Company Information
- 4.12.2 Sanofi Business Overview
- 4.12.3 Sanofi Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Sanofi Vaccines For Children Product Portfolio
- 4.12.5 Sanofi Recent Developments
- 4.13 China National Biotec
- 4.13.1 China National Biotec Company Information
- 4.13.2 China National Biotec Business Overview
- 4.13.3 China National Biotec Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 China National Biotec Vaccines For Children Product Portfolio
- 4.13.5 China National Biotec Recent Developments
5 Global Vaccines For Children Market Scenario by Region
- 5.1 Global Vaccines For Children Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Vaccines For Children Sales by Region: 2021-2032
- 5.2.1 Global Vaccines For Children Sales by Region: 2021-2026
- 5.2.2 Global Vaccines For Children Sales by Region: 2027-2032
- 5.3 Global Vaccines For Children Revenue by Region: 2021-2032
- 5.3.1 Global Vaccines For Children Revenue by Region: 2021-2026
- 5.3.2 Global Vaccines For Children Revenue by Region: 2027-2032
- 5.4 North America Vaccines For Children Market Facts & Figures by Country
- 5.4.1 North America Vaccines For Children Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Vaccines For Children Sales by Country (2021-2032)
- 5.4.3 North America Vaccines For Children Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Vaccines For Children Market Facts & Figures by Country
- 5.5.1 Europe Vaccines For Children Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Vaccines For Children Sales by Country (2021-2032)
- 5.5.3 Europe Vaccines For Children Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Vaccines For Children Market Facts & Figures by Country
- 5.6.1 Asia Pacific Vaccines For Children Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Vaccines For Children Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Vaccines For Children Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Vaccines For Children Market Facts & Figures by Country
- 5.7.1 South America Vaccines For Children Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Vaccines For Children Sales by Country (2021-2032)
- 5.7.3 South America Vaccines For Children Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Vaccines For Children Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Vaccines For Children Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Vaccines For Children Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Vaccines For Children Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Vaccines For Children Sales by Type (2021-2032)
- 6.1.1 Global Vaccines For Children Sales by Type (2021-2032) & (K Doses)
- 6.1.2 Global Vaccines For Children Sales Market Share by Type (2021-2032)
- 6.2 Global Vaccines For Children Revenue by Type (2021-2032)
- 6.2.1 Global Vaccines For Children Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Vaccines For Children Revenue Market Share by Type (2021-2032)
- 6.3 Global Vaccines For Children Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Vaccines For Children Sales by Application (2021-2032)
- 7.1.1 Global Vaccines For Children Sales by Application (2021-2032) & (K Doses)
- 7.1.2 Global Vaccines For Children Sales Market Share by Application (2021-2032)
- 7.2 Global Vaccines For Children Revenue by Application (2021-2032)
- 7.2.1 Global Vaccines For Children Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Vaccines For Children Revenue Market Share by Application (2021-2032)
- 7.3 Global Vaccines For Children Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Vaccines For Children Value Chain Analysis
- 8.1.1 Vaccines For Children Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Vaccines For Children Production Mode & Process
- 8.2 Vaccines For Children Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Vaccines For Children Distributors
- 8.2.3 Vaccines For Children Customers
9 Global Vaccines For Children Analyzing Market Dynamics
- 9.1 Vaccines For Children Industry Trends
- 9.2 Vaccines For Children Industry Drivers
- 9.3 Vaccines For Children Industry Opportunities and Challenges
- 9.4 Vaccines For Children Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst